CareDx, Inc. 2025 Q4 - Results - Earnings Call Presentation

CareDx released its Q4 2025 earnings presentation, detailing financial performance and operational updates during its February 2026 earnings call. The company highlighted revenue growth driven by its transplant diagnostics portfolio, including non-invasive surveillance solutions for organ rejection monitoring. Key focus areas included advancements in AI-driven diagnostic tools, with emphasis on improving patient outcomes through precision medicine technologies. Executives discussed strategic partnerships and regulatory milestones, though specific financial figures were not detailed in the transcript summary. The presentation underscored CareDx’s commitment to expanding its commercial footprint in transplant care while optimizing operational efficiency.